Detalhe da pesquisa
1.
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutations.
Cancer
; 130(9): 1600-1608, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100492
2.
Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
Ann Surg Oncol
; 30(3): 1663-1668, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094691
3.
Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
Gynecol Oncol
; 172: 106-114, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004303
4.
Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.
Cancer
; 128(20): 3709-3717, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996941
5.
Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Cancer
; 128(1): 94-102, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424535
6.
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences.
Breast J
; 2022: 1447545, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36685664
7.
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Genet Epidemiol
; 44(5): 442-468, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32115800
8.
Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
Cancer
; 127(19): 3605-3613, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157779
9.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Genet Med
; 23(9): 1726-1737, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113011
10.
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(10): 1269-1282, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861273
11.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med
; 22(10): 1653-1666, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665703
12.
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Ann Surg Oncol
; 27(12): 4613-4621, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720048
13.
Clinical implications of breast cancer tumor genomic testing.
Breast J
; 26(8): 1565-1571, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32696498
14.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 121(2): 180-192, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213659
15.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Breast Cancer Res Treat
; 176(3): 545-556, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054033
16.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat
; 39(5): 593-620, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446198
17.
BRCA mutations in women with inflammatory breast cancer.
Cancer
; 124(3): 466-474, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044548
18.
Development of CNS metastases and survival in patients with inflammatory breast cancer.
Cancer
; 124(11): 2299-2305, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579338
19.
ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline Testing.
Ann Surg Oncol
; 30(5): 2914-2915, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36705815
20.
ASO Visual Abstract: Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.
Ann Surg Oncol
; 30(3): 1669-1670, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210399